Chester County News and Community Website
WASHINGTON, D.C. — On Thursday, the Food and Drug Administration granted accelerated approval to repotrectinib (AUGTYRO), a new drug for treating certain advanced solid tumors in patients aged 12 and …
FDA Grants Accelerated Approval for New Cancer Drug Repotrectinib Read More
WASHINGTON, D.C. — The FDA on Thursday updated its recommendations for manufacturers of COVID-19 vaccines for the 2024-2025 season. The agency now advises that vaccines should target the KP.2 strain …
FDA Updates COVID-19 Vaccine Guidance to Target New Strain Read More
WASHINGTON, D.C. — The FDA on Wednesday granted full approval to the drug selpercatinib, marketed as Retevmo, for treating advanced thyroid cancer in both adults and children aged 2 and …
FDA Grants Full Approval to Retevmo for Advanced Thyroid Cancer Read More
WASHINGTON, D.C. — The FDA on Tuesday approved phenylpropanolamine hydrochloride chewable tablets for the control of urinary incontinence in dogs. This is the first generic version of these tablets, which …
FDA Approves Generic Chewable Tablets for Dog Incontinence Read More
WASHINGTON, D.C. — On Monday, the Food and Drug Administration (FDA) approved Iqirvo (elafibranor) oral tablets to treat primary biliary cholangitis (PBC). This rare autoimmune disease causes inflammation and damage …
FDA Approves New Treatment for Rare Liver Disease Read More
WASHINGTON, D.C. — On Friday, the Food and Drug Administration (FDA) approved Arexvy, a vaccine designed to prevent lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV), for …
FDA Approves New RSV Vaccine for Individuals Aged 50-59 Read More
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has announced promising results from its recent Phase II/III clinical trial for its lead drug candidate, Buntanetap, targeting Alzheimer’s disease (AD). The …
Annovis Bio’s Alzheimer’s Drug Shows Promise in Phase II/III Trial Read More
LANGHORNE, PA — Biomarker testing for patients with non-small cell lung cancer (NSCLC) in the United States is significantly underutilized, according to a study by Amplity Health. Presented at the …
Amplity Health Study Reveals Underutilization of Biomarker Testing in Lung Cancer Treatment Read More
WASHINGTON, D.C. — The Food and Drug Administration (FDA) announced Friday that it has advised vaccine manufacturers to produce a monovalent COVID-19 vaccine for the 2024-2025 season. This new vaccine …
FDA Recommends New Monovalent COVID-19 Vaccine for 2024-2025 Read More
WASHINGTON, D.C. — The Food and Drug Administration (FDA) has approved a new drug, imetelstat (Rytelo), developed by Geron Corporation. This medication is designed for adults with certain types of …
FDA Approves New Treatment for Certain Myelodysplastic Syndromes Read More